Strategies and Recommendations for Using a Data〥riven and Risk〣ased Approach in the Selection of First﹊n〩uman Starting Dose: An International Consortium for Innovation and Quality in Pharmaceutical Development (IQ) Assessment

发表于 2026-7-9 14:00:18

期刊：Clinical Pharmacology & Therapeutics

文献作者：Michael W. Leach; David O. Clarke; Sherri Dudal; Chao Han; Chunze Li; Zheng Yang; Frank R. Brennan; Wendy J. Bailey; Yingxue Chen; Antoine Deslandes; Lise I. Loberg; Kapil Mayawala; Mark C. Rogge; Marque Todd; Nagendra V. Chemuturi

出版日期：2021-6-

DOI号：10.1002/cpt.2009

下载链接：https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.2009

文献链接：https://doi.org/10.1002/cpt.2009

当前文献来源于 Wiley。

备注信息：

发表于 2026-7-9 14:00:19

: 当前求助已完成，请重新发起求助。
已完结状态的附件将会在24小时内删除。

[Wiley] Strategies and Recommendations for Using a Data〥riven and Risk〣ased Approach in the Selection of First﹊n〩uman Starting Dose: An International Consortium for Innovation and Quality in Pharmaceutical Development (IQ) Assessment

已采纳

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[Wiley] Strategies and Recommendations for Using a Data〥riven and Risk〣ased Approach in the Selection of First﹊n〩uman Starting Dose: An International Consortium for Innovation and Quality in Pharmaceutical Development (IQ) Assessment 一键复制